Reuters logo
BRIEF-U.S. FDA approves Auryxia tablets as treatment for people with iron deficiency anemia and chronic kidney disease
November 7, 2017 / 12:23 PM / in 11 days

BRIEF-U.S. FDA approves Auryxia tablets as treatment for people with iron deficiency anemia and chronic kidney disease

Nov 7 (Reuters) - Keryx Biopharmaceuticals Inc

* U.S. FDA approves Auryxia® (ferric citrate) tablets as a treatment for people with iron deficiency anemia and chronic kidney disease, not on dialysis Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below